Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Censoring Survival Data01:09

Censoring Survival Data

243
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
243
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

199
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
199
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

292
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
292
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

404
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
404
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

274
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
274
Truncation in Survival Analysis01:09

Truncation in Survival Analysis

318
Truncation in survival analysis refers to the exclusion of individuals or events from the dataset based on specific criteria related to the time of the event. This exclusion can happen in two primary forms: left truncation and right truncation.
Left truncation occurs when individuals who experienced the event of interest before a certain time are not included in the study. This is often due to a "delayed entry" into the study where only those who survive until a certain entry point are...
318

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Win Ratio as an Effect Size Measure Under Non-Proportional Hazards: A Comparison With Difference in Restricted Mean Survival.

Statistics in medicine·2026
Same author

Comparing adaptive treatment strategies in two-stage randomized trials with grouped survival data.

Lifetime data analysis·2026
Same author

Temporary Knockdown of p53 During Focal Limb Irradiation Increases the Development of Sarcomas.

Cancer research communications·2023
Same author

Efficient estimation of grouped survival models.

BMC bioinformatics·2019
Same author

Sample size calculation for studies with grouped survival data.

Statistics in medicine·2018

Related Experiment Video

Updated: Sep 16, 2025

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.3K

Analysis of interval censored survival data in sequential multiple assignment randomized trials.

Zhiguo Li1

  • 1Department of Biostatistics and Bioinformatics, Duke University, Durham, NC, USA. zhiguo.li@duke.edu.

Lifetime Data Analysis
|July 11, 2025
PubMed
Summary

This study introduces new statistical methods for analyzing interval-censored time-to-event data in adaptive treatment strategies within sequential multiple assignment randomized trials (SMART). The methods enable robust inference for complex clinical trial designs previously lacking appropriate analysis techniques.

Keywords:
Adaptive treatment strategyInterval censored dataProportional hazards modelSequential multiple assignment randomized trialWeighted spline-based sieve maximum likelihood

More Related Videos

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.2K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.6K

Related Experiment Videos

Last Updated: Sep 16, 2025

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.3K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.2K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.6K

Area of Science:

  • Biostatistics
  • Clinical Trials Methodology
  • Survival Analysis

Background:

  • Existing methods for sequential multiple assignment randomized trials (SMART) primarily address continuous or right-censored data.
  • Interval-censored time-to-event outcomes, common in psychology and other fields, lack established analysis techniques within SMART designs.

Purpose of the Study:

  • To develop and validate statistical methods for analyzing interval-censored time-to-event outcomes in SMART studies.
  • To provide a framework for making inferences about adaptive treatment strategies when event times are only known within intervals.

Main Methods:

  • Proposes a weighted spline-based sieve maximum likelihood method for inference.
  • Utilizes a Wald test for assessing group differences.
  • Derives asymptotic properties of the hazard ratio estimator and addresses variance estimation.

Main Results:

  • The developed methods provide a viable approach for handling interval-censored data in SMART.
  • Simulation studies assess the finite sample performance of the proposed methods.
  • The methods are applied to data from the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) trial.

Conclusions:

  • This research fills a critical gap in the analysis of SMART studies with interval-censored outcomes.
  • The proposed methods offer a statistically sound approach for complex clinical trial data.
  • The findings have implications for designing and analyzing future adaptive treatment trials.